Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CDA encodes an enzyme involved in pyrimidine salvaging. Additionally we are shipping CDA Antibodies (74) and CDA Proteins (47) and many more products for this protein.
Showing 2 out of 14 products:
results indicate that rs2072671 in CDA may be an important prognostic marker in NK-AML (show RUNX1 ELISA Kits) patients.
tumor cell lines that are susceptible to epigenetic nucleosides overexpress cytidine deaminase (CDA); CDA converts 5hmdC and 5fdC into variants of uridine that are incorporated into DNA, resulting in accumulation of DNA damage, and ultimately, cell death
RNA expression of deoxycytidine kinase (DCK (show DCK ELISA Kits)), human equilibrative nucleoside transporter-1 (ENT1 (show SLC29A1 ELISA Kits)) and ribonucleotide reductase M1 (RRM1 (show RRM1 ELISA Kits)) were significantly higher and cytidine deaminase (CDA) was significantly lower in ex vivo Ara (show FOXC1 ELISA Kits)-C sensitive samples.
stimulation of PARP-1 (show PARP1 ELISA Kits) activity in CDA-deficient cells restores replication and, thus, chromosome segregation. Moreover, increasing intracellular dCTP levels generates under-replication-induced sister-chromatid bridges as efficiently as PARP-1 (show PARP1 ELISA Kits) knockdown
n the multivariate Cox regression analysis, we found that age at diagnosis, wild-type genotype of the CDA A79C polymorphism, and wild-type genotype of the dCK (show DCK ELISA Kits) C360G polymorphism were the most significant prognostic factors for predicting the risk of death
Single nucleotide polymorphisms in cytidine deaminase gene were associated with the efficacy of gemcitabine in Biliary Tract Cancer.
Polymorphisms in ABCB1 (show ABCB1 ELISA Kits), CDA, ENOSF1 (show ENOSF1 ELISA Kits),and TYMS (show TYMS ELISA Kits) could help to predict specific and overall severe adverse reactions to capecitabine.
miR (show MLXIP ELISA Kits)-484-modulated cytidine deaminase has a dual impact in promoting chemoresistance and suppressing cell proliferation in breast cancer
This case report calls for further prospective studies investigating the exact role that CDA status plays in the clinical outcome of patients treated with azacytidine.
The A79C CDA polymorphism did not show a significant impact on the response rate to gemcitabine in NSCLC patients, while the wild type CDA genotype was indeed correlated to a lower rate of incidence of severe anemia in patients taking gemcitabine.
Data indicate that a combination cytosine deaminase (CDA)/uracil phosphoribosyltransferase protein (UPRT (show UPRT ELISA Kits))-expressing adipose tissue-derived mesenchymal stem cells (AT-MSCs) with lysomustine has a superior antitumor effect in the lung carcinoma model compared to monotherapies with transfected AT-MSCs or lysomustine alone.
Activation-induced cytidine deaminase (show AICDA ELISA Kits) plays an important role in the containment of autoimmune diseases by negative regulation of autoreactive B cells.
This gene encodes an enzyme involved in pyrimidine salvaging. The encoded protein forms a homotetramer that catalyzes the irreversible hydrolytic deamination of cytidine and deoxycytidine to uridine and deoxyuridine, respectively. It is one of several deaminases responsible for maintaining the cellular pyrimidine pool. Mutations in this gene are associated with decreased sensitivity to the cytosine nucleoside analogue cytosine arabinoside used in the treatment of certain childhood leukemias.
, CytiDine Deaminase family member (cdd-1)
, CytiDine Deaminase family member (cdd-2)
, cytidine aminohydrolase
, cytosine nucleoside deaminase
, small cytidine deaminase